These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 18434953)

  • 21. FDA issues import alert against unapproved mail-order drugs.
    Am J Hosp Pharm; 1992 May; 49(5):1024. PubMed ID: 1595726
    [No Abstract]   [Full Text] [Related]  

  • 22. Texas task force to target fraudulent AIDS treatments.
    Tex Med; 1990 May; 86(5):16. PubMed ID: 2343414
    [No Abstract]   [Full Text] [Related]  

  • 23. Unlabeled drug samples and the learned intermediary: the case for drug company liability without preemption.
    Poser S
    Food Drug Law J; 2007; 62(4):653-94. PubMed ID: 18557225
    [No Abstract]   [Full Text] [Related]  

  • 24. FDA warns Bayer about illegally marketing two over the counter products containing aspirin.
    Kmietowicz Z
    BMJ; 2008 Nov; 337():a2402. PubMed ID: 18984638
    [No Abstract]   [Full Text] [Related]  

  • 25. Avoid drug-marketing traps.
    Estabrook MA
    Manag Care; 2003 Feb; 12(2):48-9. PubMed ID: 12658859
    [No Abstract]   [Full Text] [Related]  

  • 26. Psychopharmacology news.
    Silva RR
    J Child Adolesc Psychopharmacol; 2007 Aug; 17(4):531-2. PubMed ID: 17822347
    [No Abstract]   [Full Text] [Related]  

  • 27. FDA warns about counterfeit drug.
    AIDS Patient Care STDS; 2003 May; 17(5):258. PubMed ID: 12825589
    [No Abstract]   [Full Text] [Related]  

  • 28. Fraudulent, unapproved influenza-related products.
    FDA Consum; 2006; 40(2):8. PubMed ID: 16671248
    [No Abstract]   [Full Text] [Related]  

  • 29. Personal effects. Can emotive marketing through relationships influence rational doctors' prescriptions?
    Srivastava RK
    Mark Health Serv; 2007; 27(4):29-32. PubMed ID: 18186452
    [No Abstract]   [Full Text] [Related]  

  • 30. Internet eases negotiations for FDA, drug firms.
    Goedert J
    Health Data Manag; 2001 Mar; 9(3):14-5. PubMed ID: 11277031
    [No Abstract]   [Full Text] [Related]  

  • 31. FDA notifications. Final rule is out on OTC vaginal contraceptives and spermicides.
    AIDS Alert; 2008 Feb; 23(2):22-3. PubMed ID: 18574883
    [No Abstract]   [Full Text] [Related]  

  • 32. Pharmaceutical inserts: legal consequences.
    Hirsh HL
    Hosp Med Staff; 1979 Jul; 8(7):2-6. PubMed ID: 10242674
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Use of drugs for unlabeled indications.
    Nightingale SL
    Am Fam Physician; 1986 Sep; 34(3):269. PubMed ID: 3751849
    [No Abstract]   [Full Text] [Related]  

  • 34. Medication use during pregnancy and lactation: the new FDA drug labeling.
    Tillett J
    J Perinat Neonatal Nurs; 2015; 29(2):97-9. PubMed ID: 25919597
    [No Abstract]   [Full Text] [Related]  

  • 35. Did FDA jump the gun?
    Archambault GF
    Hosp Formul; 1977 Oct; 12(10):722. PubMed ID: 10305387
    [No Abstract]   [Full Text] [Related]  

  • 36. FDA notifications. Watch for counterfeit lot of Serostim.
    AIDS Alert; 2002 Aug; 17(8):102. PubMed ID: 12647692
    [No Abstract]   [Full Text] [Related]  

  • 37. Drug promotion.
    Cohen SN
    N Engl J Med; 1995 Apr; 332(15):1032; author reply 1033. PubMed ID: 7885414
    [No Abstract]   [Full Text] [Related]  

  • 38. Danger: counterfeit Serostim (human growth hormone).
    AIDS Treat News; 2001 May; (365):5. PubMed ID: 11547414
    [No Abstract]   [Full Text] [Related]  

  • 39. Drug interactions: Who warns the patient.
    CMAJ; 1999 Jul; 161(2):117. PubMed ID: 10454842
    [No Abstract]   [Full Text] [Related]  

  • 40. An FDA guide to choosing medical treatments.
    Stehlin IB
    FDA Consum; 1995 Jun; 29(5):10-4. PubMed ID: 10143244
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.